Evidence map›Paper›PMID 38700324›Full record

ArticleMicrobiology spectrum2024

Preclinical validation of an

Laurent Chorro, Duston Ndreu, Axay Patel, Srinivas Kodali, Zhenghui Li, David Keeney, Kaushik Dutta, Aniruddha Sasmal, Arthur Illenberger, C Lynn Torres and 6 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. A cynomolgus monkeyInfection and immunity · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laurent ChorroPfizer Vaccine Research and Development, Pearl River, New York, USA.
Duston NdreuPfizer Vaccine Research and Development, Pearl River, New York, USA.
Axay PatelPfizer Vaccine Research and Development, Pearl River, New York, USA.
Srinivas KodaliPfizer Vaccine Research and Development, Pearl River, New York, USA.
Zhenghui LiPfizer Vaccine Research and Development, Pearl River, New York, USA.
David KeeneyPfizer Vaccine Research and Development, Pearl River, New York, USA.
Kaushik DuttaPfizer Vaccine Research and Development, Pearl River, New York, USA.
Aniruddha SasmalPfizer Vaccine Research and Development, Pearl River, New York, USA.
Arthur IllenbergerPfizer Vaccine Research and Development, Pearl River, New York, USA.
C Lynn TorresPfizer Vaccine Research and Development, Pearl River, New York, USA.
Rosalind PanPfizer Vaccine Research and Development, Pearl River, New York, USA.
Natalie C Silmon de MonerriPfizer Vaccine Research and Development, Pearl River, New York, USA.
Ling ChuPfizer Vaccine Research and Development, Pearl River, New York, USA.
Raphael SimonPfizer Vaccine Research and Development, Pearl River, New York, USA.
Annaliesa S AndersonPfizer Vaccine Research and Development, Pearl River, New York, USA.
Robert G K DonaldPfizer Vaccine Research and Development, Pearl River, New York, USA.ORCID 0000-0002-1002-954X

Funding

Pfizer Inc
6 · The paper itself

Abstract

A US collection of invasive IMPORTANCE: The

Indexed as

Escherichia coliEscherichia coli InfectionsGlycoconjugatesO AntigensAnimalsAntibodies, BacterialBacteremiaBacterial ProteinsDisease Models, AnimalEscherichia coli VaccinesFemaleHumansMiceMultilocus Sequence TypingSerogroupVaccines, ConjugateAntibodies, BacterialBacterial ProteinsCRM197 (non-toxic variant of diphtheria toxin)Escherichia coli VaccinesGlycoconjugatesO AntigensVaccines, ConjugateEscherichia coliglycoconjugate vaccineK1 capsuleO-antigen

Identifiers

PMID38700324
PMCPMC11237799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.